← Back to catalogue

TdT Control Cell Suspension

FDA UDI

Class I (US FDA UDI)

by Supertechs, Inc.

Identity

Trade Name
TdT Control Cell Suspension FDA UDI
Generic Name
Terminal deoxynucleotidyl transferase (TdT) IVD, control FDA UDI
Device Name
Cell suspension containing fixed human lymphoblastoid REH (TdT+) and RA-1 (TdT-) cells 50% TdT+ and 50% TdT- cells at a concentration of 2 x 10^7 cells/mL 1.0 mL bottle for approximately 20 tests FDA UDI
Model / Reference
9500A FDA UDI
Description
Cell suspension containing fixed human lymphoblastoid REH (TdT+) and RA-1 (TdT-) cells 50% TdT+ and 50% TdT- cells at a concentration of 2 x 10^7 cells/mL 1.0 mL bottle for approximately 20 tests FDA UDI

Identifiers

Catalog Number
9500 FDA UDI
Primary DI / UDI-DI
B7829500A07 FDA UDI
FDA Product Code
KIR FDA UDI
GMDN Term
Terminal deoxynucleotidyl transferase (TdT) IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.2280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Terminal deoxynucleotidyl transferase (TdT) IVD, control

TdT Control Cell Suspension by Supertechs, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Terminal deoxynucleotidyl transferase (TdT) IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Supertechs, Inc.

Sources (1)

  • FDA UDI 4e9f780d-d458-454c-a8bc-7735be7dd124 35 fields · synced Jun 1, 2026